These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31727565)

  • 1. Paternal safety of anti-rheumatic medications.
    Bermas BL
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():77-84. PubMed ID: 31727565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.
    Mouyis M; Flint JD; Giles IP
    Semin Arthritis Rheum; 2019 Apr; 48(5):911-920. PubMed ID: 30220537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.
    Perez-Garcia LF; Dolhain RJEM; Vorstenbosch S; Bramer W; van Puijenbroek E; Hazes JMW; Te Winkel B
    Hum Reprod Update; 2020 Nov; 26(6):961-1001. PubMed ID: 32743663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No excess risks in offspring with paternal preconception exposure to disease-modifying antirheumatic drugs.
    Wallenius M; Lie E; Daltveit AK; Salvesen KÅ; Skomsvoll JF; Kalstad S; Lexberg ÅS; Mikkelsen K; Kvien TK; Østensen M
    Arthritis Rheumatol; 2015 Jan; 67(1):296-301. PubMed ID: 25418443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding].
    Häfeli C; Förger F
    Z Rheumatol; 2021 Oct; 80(8):716-725. PubMed ID: 34581874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review.
    Zakhem GA; Motosko CC; Mu EW; Ho RS
    J Am Acad Dermatol; 2019 Apr; 80(4):957-969. PubMed ID: 30287313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antirheumatic drugs in pregnancy and lactation.
    Temprano KK; Bandlamudi R; Moore TL
    Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How safe are anti-rheumatic drugs during pregnancy?
    Østensen M; Förger F
    Curr Opin Pharmacol; 2013 Jun; 13(3):470-5. PubMed ID: 23522967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antirheumatic medications in pregnancy and breastfeeding.
    Birru Talabi M; Clowse MEB
    Curr Opin Rheumatol; 2020 May; 32(3):238-246. PubMed ID: 32205567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R
    Med Clin (Barc); 2016 Oct; 147(8):352-360. PubMed ID: 27389618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxicity of methotrexate in male fertility and paternal teratogenicity.
    Gutierrez JC; Hwang K
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):51-58. PubMed ID: 27590039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
    Meserve J; Luo J; Zhu W; Veeravalli N; Bandoli G; Chambers CD; Singh AG; Boland BS; Sandborn WJ; Mahadevan U; Singh S
    Gastroenterology; 2021 Jul; 161(1):107-115.e3. PubMed ID: 33744307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation.
    Levy RA; de Jesús GR; de Jesús NR; Klumb EM
    Autoimmun Rev; 2016 Oct; 15(10):955-63. PubMed ID: 27490204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding].
    Ostensen M
    Z Rheumatol; 2006 May; 65(3):217-20, 222-4. PubMed ID: 16670813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety issues of biologics in pregnant patients with rheumatic diseases.
    Ostensen M
    Ann N Y Acad Sci; 2014 May; 1317():32-8. PubMed ID: 24840548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.
    Østensen M; Lockshin M; Doria A; Valesini G; Meroni P; Gordon C; Brucato A; Tincani A
    Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii28-31. PubMed ID: 18504282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy.
    Bermas BL
    Curr Opin Rheumatol; 2014 May; 26(3):334-40. PubMed ID: 24663106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breastfeeding and drug management in connective tissue and rheumatic diseases].
    Weber JC; Kuhnert C
    Rev Med Interne; 2008 Dec; 29(12):1017-23. PubMed ID: 18799245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK; Engeland A; Furu K
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.